Lung specialist tells Senate committee that Ivermectin anti-parasite medicine is “wonder drug” for COVID-19

by Karen Faulkner, Worthy News Correspondent

(Worthy News) – A lung specialist at Aurora St. Luke’s Medical Center in Milwaukee has pleaded with a Senate committee to review his study of an anti-parasite drug which he says has produced dramatically positive results in treating hospitalized COVID-19 patients, CNS News reports.

Pulmonologist Dr. Pierre Kory told a hearing of the Senate Homeland Security Committee Tuesday that Ivermectin is a powerful anti-viral and anti-inflammation agent that has proved to be “wonder drug” for coronavirus patients.

While Ivermectin has been used to treat parasite conditions for decades, it has not yet been approved to treat COVID-19, CNS News reports. Accordingly, Dr. Kory reportedly pleaded with the Senate committee to review a study he conducted with two researchers who won the Nobel Prize for Medicine in 2015 for their study on the effectiveness of Ivermectin in eradicating parasitic diseases.

“All I ask is for the NIH to review our data that we’ve compiled of all of the emerging data — we have almost 30 studies… The most profound evidence we have is in the hospitalized patients. We have four randomized control trials there, multiple observation trials, all showing the same thing, you will not die, or you will die at much, much, much lower rates…It is proving to be a wonder drug,” Dr. Kory said.

“We have 100,000 patients in the hospital right now, dying. I’m a lung specialist. I’m an ICU specialist. I’ve cared for more dying COVID patients than anyone can imagine. They’re dying because they can’t breathe, Dr. Kory continued. “They can’t breathe…And I watch them every day. They die. By the time they get to me in ICU, they’re already dying, they’re almost impossible to recover…If you look at my manuscript, and if I have to go back to work next week, any further deaths are going to be needless deaths, and I cannot be traumatized by that.”

Following Dr. Kory’s presentation, Committee Chair Sen. Ron Johnson (R-Wis.) promised that “before the day is out, we’ll have a letter…to the NIH asking them to review” the study, CNS News reports.

Latest Worthy News